Osteogenic differentiation of bone marrow mesenchymal stem cells of ovariectomized and non-ovariectomized female rats with thyroid dysfunction

Pathology Research and Practice

Volumn 209, Issue 1, 2013, Pages 44-51

  Boeloni, Jankerle N ^a   de M Ocarino, Natália ^a   Silva, Juneo F ^a   Corrêa, Cristiane R ^a   Bertollo, Caryne M ^a   Hell, Rafaela C R ^a   de M Pereira, Marivalda ^a   Goes, Alfredo M ^a   Serakides, Rogéria ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Female rats; Mesenchymal stem cells; Osteogenic differentiation; Ovariectomy; Thyroid dysfunctions

Indexed keywords

ALKALINE PHOSPHATASE; BONE SIALOPROTEIN; COLLAGEN TYPE 1; OSTEOCALCIN; OSTEOPONTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FREE THYROXINE INDEX; HEMATOPOIETIC STEM CELL; HORMONE DETERMINATION; HYPERTHYROIDISM; HYPOTHYROIDISM; MESENCHYMAL STEM CELL; MINERALIZATION; NONHUMAN; OSTEOBLAST; OVARIECTOMY; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; FEMALE; HYPERTHYROIDISM; HYPOTHYROIDISM; MESENCHYMAL STROMAL CELLS; OSTEOGENESIS; OVARIECTOMY; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84872373331     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2012.10.004     Document Type: Article

References (54)

1. Abe U., Sun L., Mechanick J., Iqbal J., Yamoah K., Baliram R., Arabi A., Moonga B.S., Davies T.F., Zaidi M. Bone loss in thyroid disease: role of low TSH and high thyroid hormone. Ann. N.Y. Acad. Sci. 2007, 1116:383-391.
2. Affinito P., Sorrentino C., Farace M.J., di Carlo C., Moccia G., Canciello P., Palomba S., Nappi C. Effects of thyroxine therapy on bone metabolism in postmenopausal women with hypothyroidism. Acta Obstet. Gynecol. Scand. 1996, 75:843-848.
3. Allain T.J., McGregor A.M. Thyroid hormones and bone. J. Endocrinol. 1993, 139:9-18.
4. Allain T.J., Thomas M.R., McGregor A.M., Salisbury J.R. A histomorphometric study of bone changes in thyroid dysfunction in rats. Bone 1995, 16:505-509.
5. Asai S., Cao X., Yamauchi M., Funahashi K., Ishiguro N., Kambe F. Thyroid hormone non-genomically suppresses Src thereby stimulating osteocalcin expression in primary mouse cauvarial osteoblasts. Biochem. Biophys. Res. Commun. 2009, 387:92-96.
6. Barret-Connor E., Weiss T.W., McHorney C.A., Miller P.D., Siris E.S. Predictors of falls among postmenopausal women: results from the national osteoporosis risk assessment (NORA). Osteoporos. Int. 2009, 20:715-722.
7. Ben-Shlomo A., Hagag P., Evans S., Weiss M. Early postmenopausal bone loss in hyperthyroidism. Maturitas 2001, 39:19-27.
8. Bjoro T., Holmen J., Krüger O., Midthjell K., Hunstad K., Schreiner T., Sandnes L., Brochmann H. Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population. The health study of Nord-Trondelag (HUNT). Eur. J. Endocrinol. 2000, 143:639-647.
9. Bland R. Steroid hormone receptor expression and action in bone. Clin. Sci. 2000, 98:217-240.
10. Boeloni J.N., Ocarino N.M., Bozzi A.B., Silva J.F., Castanheira P., Goes A.M., Serakides R. Dose-dependent effects of triiodothyronine on osteogenic differentiation of rat bone marrow mesenchymal stem cells. Horm. Res. 2009, 71:88-97.
11. Boonya-Ussadom T., Punkaew B., Sriassawaamom N. A comparative study of bone mineral density between premenopausal women with hyperthyroidism and healthy premenopausal women. J. Med. Assoc. Thai. 2010, 93:S1-S5.
12. Bruno A.N., Pochmann D., Ricachenevsky F.K., Bonan C.D., Barreto-Chaves M.L., Sarkis J.J.F. 5'nucleotidase activity is altered by hypo- and hyperthyroidism in platelets from adult rats. Platelets 2005, 16:25-30.
13. Campos-Pastor M.M., Muños-Torres M., Escobar-Jiménez F., Almodóvar M.R., Jódar G.E. Bone mass in females with different thyroid disorders: influence of menopausal status. Bone Miner. 1993, 21:1-8.
14. Carneiro-Ramos M.S., Silva V.B., Júnior M.B.C., Battastini A.M., Sarkis J.J., Barreto-Chaves M.L. Thyroid hormone stimulates 5'-ecto-nucleotidase of neonatal rat ventricular myocytes. Mol. Cell. Biochem. 2004, 265:195-201.
15. Cipriani C., Romgnoli E., Scarpiello A., Angelozzi M., Montesano T., Minisola S. Phalangeal quantitative ultrasound and bone mineral density in evaluating cortical bone loss: a study in postmenopausal women with primary hyperthyroidism and subclinical iatrogenic hyperthyroidism. J. Clin. Densitom. 2009, 12:456-460.
16. Compston J.E. Bone marrow and bone: a functional unit. J. Endocrinol. 2002, 173:387-394.
17. Datta H.K., Ng W.F., Walker J.A., Tuck S.P., Varanasi S.S. The cell biology of bone metabolism. J. Clin. Pathol. 2008, 61:577-587.
18. Díez J.J., Molina I., Ibars M.T. Prevalence of thyroid dysfunction in adults over age 60 years from an urban community. Exp. Clin. Endocrinol. Diabetes 2003, 111:480-485.
19. Ernst M., Froesch E.R. Triiodothyronine stimulates proliferation of osteoblast-like cells in serum-free culture. FEBS Lett. 1987, 220:163-166.
20. Földes J., Tarján G., Szathmari M., Varga F., Krasznai I., Horvath C. Bone mineral density in patient is with endogenous subclinical hyperthyroidism: is this thyroid status a risk factor for osteoporosis?. Clin. Endocrinol. (Oxf.) 1993, 39:521-527.
21. Garnero P., Vassy V., Bertholin A., Riou J.P., Delmas P.D. Markers of bone turnover in hyperthyroidism and the effects of treatment. J. Clin. Endocrinol. Metab. 1994, 78:955-959.
22. Gouveia H.A., Jorgetti V., Bianco A.C. Effects of thyroid hormone administration and estrogen deficiency on bone mass of female rats. J. Bone Miner. Res. 1997, 12:2098-2107.
23. Gouveia C.H., Schultz J.J., Bianco A.C., Brent G.A. Thyroid hormone stimulation of osteocalcin gene expression in ROS 17/2.8 cells is mediated by transcriptional and post-transcriptional mechanisms. J. Endocrinol. 2001, 170:667-675.
24. Gruber R., Czerwenka K., Wolf F., Ho G.M., Willheim M., Peterlik M. Expression of the vitamin D receptor, of estrogen and thyroid hormone receptor α- and β-isoforms, and of the androgen receptor in cultures of native mouse bone marrow and of stromal/osteoblastic cells. Bone 1999, 24:465-473.
25. Hell R.C.R, Boeloni J.N., Ocarino N.M., Silva J.F., Goes A.M., Serakides R. Efeito da triiodotironina na expressão das proteínas ósseas durante a diferenciação osteogênica de células-tronco mesenquimais. Arq. Bras. Endocrinol. Metab. 2011, 55:339-344.
26. Klaushofer K., Varga F., Glantschnig H., Fratzl-Zelman N., Czerwenka E., Leis H.J., Koller K., Peterlik M. The regulatory role of thyroid hormones in bone cell growth and differentiation. J. Nutr. 1995, 125:1996S-2003S.
27. Kung A.W.C., Pun K.K. Bone mineral density in premenopausal women receiving long-term physiological doses of levothyroxine. JAMA 1991, 265:2688-2691.
28. Lee H., Huang G., Chiang H., Chiou L.L., Chen M.H., Hsieh C.H., Jiang C.C. Multipotential mesenchymal stem cells from femoral bone marrow near the site of osteonecrosis. Stem Cells 2003, 21:190-199.
29. Mao Y.S., Liu Z.M., Chen C.X., Zhu Z.W., Hong Z.L. Ningbo thyroid dysfunction prevalence study: a cross-sectional survey in an employees-cohort. Chin. Med. J. 2010, 123:1673-1678.
30. Marie P.J. The molecular genetics of bone formation. Am. J. Pharmacogenomics 2001, 1:175-187.
31. Mundy G.R., Shapiro J.L., Bandelin J.G., Canalis E.M., Raisz L.G. Direct stimulation of bone resorption by thyroid hormones. J. Clin. Invest. 1976, 58:529-534.
32. Nadri S., Soleimani M., Hosseni R.H., Massumi M., Atashi A., Izadpanah R. An efficient method of isolation of murine bone marrow mesenchymal stem cells. Int. J. Dev. Biol. 2007, 51:723-729.
33. Ocarino N.M., Marubayashi U., Cardoso T.G.S., Guimarães C.V., Silva A.E., Torres R.C., Serakides R. Physical activity in osteopenia treatment improved the mass of bones directly and indirectly submitted to mechanical impact. J. Musculoskelet. Neuronal Interact. 2007, 7:84-93.
34. Ocarino N.M., Boeloni J.N., Goes A.M., Silva J.F., Marubayashi U., Serakides R. Osteogenic differentiation of mesenchymal stem cells from osteopenic rats subjected to physical activity with and without nitric oxide synthase inhibition. Nitric Oxide 2008, 19:320-325.
35. Ocarino N.M., Boeloni J.N., Jorgetti V., Gomes D.A., Goes A.M., Serakides R. Intra-bone marrow injection of mesenchymal stem cells improves the femur bone mass of osteoporotic female rats. Connect. Tissue Res. 2010, 51:426-433.
36. Payushina O.V., Domaratskaya E.I., Starostin V.I. Mesenchymal stem cells: sources, phenotype, and differentiation potential. Cell Biol. 2006, 33:6-25.
37. Pearce E.N. Thyroid dysfunction in perimenopausal and postmenopausal women. Menopause Int. 2007, 13:8-13.
38. Raisz L.G. Physiology and pathophysiology of bone remodeling. Clin. Chem. 1999, 45:1353-1358.
39. Resta R., Thompson L.F. T cell signalling through CD73. Cell. Signal. 1997, 9:131-139.
40. Ribeiro A.F.C., Serakides R., Ocarino N.M., Nunes V.A. Efeito da associação hipotireoidismo castração no osso e nas paratireóides de ratas adultas. Arq. Bras. Endocrinol. Metab. 2004, 48:525-534.
41. Schäffler A., Büchler C. Concise review: adipose tissue-derived stromal cells - basic and clinical implications for novel cell-based therapies. Stem Cells 2007, 25:818-827.
42. Schoutens A., Laurent E., Markowicz E., Lisart J., De Maertelaer V. Serum triiodothyronine, bone turnover, and bone mass changes in euthyroid pre- and postmenopausal women. Calcif. Tissue Int. 1991, 49:95-100.
43. Serakides R., Nunes V.A., Nascimento E.F., Silva C.M., Ribeiro A.F.C. Relação tireóide-gônadas e níveis plasmáticos de fósforo, cálcio e fosfatase alcalina em ratas. Arq. Bras. Med. Vet. Zootec. 2000, 52:579-585.
44. Serakides R., Nunes V.A., Ocarino N.M., Nascimento E.F. Efeito da associação hipertireoidismo-castração no osso de ratas adultas. Arq. Bras. Endocrinol. Metab. 2004, 48:875-884.
45. Serakides R., Ocarino N.M., Magalhães F.C., Souza C.A., Leite E.D., Freitas E.S. Histomorfometria óssea de ratas hipertireóideas lactantes e não-lactantes. Arq. Bras. Endocrinol. Metab. 2008, 52:677-683.
46. Siddiqi A., Parsons M.P., Lewis J.L., Monson J.P., Williams G.R., Burrin J.M. TR expression and function in human bone marrow stromal and osteoblast-like cells. J. Clin. Endocrinol. Metab. 2002, 87:906-914.
47. Tae S., Lee S., Park J., Im G. Mesenchymal stem cells for tissue engineering and regenerative medicine. Biomed. Mater. 2006, 1:63-71.
48. Tropel P., Noël D., Platet N., Legrand P., Benabid A.L., Berger F. Isolation and characterization of mesenchymal stem cells from adult mouse bone marrow. Exp. Cell Res. 2004, 295:395-406.
49. Valério P., Pereira M.M., Goes A.M., Leite M.F. The effect of ionic products from bioactive glass dissolution on osteoblast proliferation and collagen production. Biomaterials 2004, 25:2941-2948.
50. Varga F., Rumpler M., Luegmayr E., Fratzl-Zelman N., Glantschnig H., Klaushofer K. Triiodothyronine, a regulator of osteoblastic differentiation: depression of histone H4, attenuation of c-fos/c-fun, and induction of osteocalcin expression. Calcif. Tissue Int. 1997, 61:404-411.
51. Wang L., Zhou X., Zhou T., Ma D., Chen S., Zhi X., Yin L., Shao Z., Ou Z., Zhou P. Ecto-5'-nucleotidase promotes invasion, migration and adhesion of human breast cancer cells. J. Cancer Res. Clin. Oncol. 2008, 134:365-372.
52. Wiersinga W.M. Subclinical hypothyroidism and hyperthyroidism. I. Prevalence and clinical relevance. Neth. J. Med. 1995, 46:197-204.
53. Wink M.R., Tamajusuku A.S.K., Braganhol E., Casali E.A., Barreto-Chaves M.L., Sarkis J.J., Battastini A.M. Thyroid hormone upregulates ecto-5'-nucleotidase/CD73 in C6 rat glioma cells. Mol. Cell. Endocrinol. 2003, 205:107-114.
54. Yen P.M. Physiological and molecular basis of thyroid hormone. Physiol. Rev. 2001, 81:1097-1141.